Sian Billson

Head of Life Sciences, Stratagem IPM Ltd

Sian joined Stratagem in 2024 to lead the Chemistry and Life Sciences Patents team, bringing with her more than 25 years of experience from the patents department at pharmaceutical giant GSK. Throughout her career, she has developed and delivered global, commercially driven IP strategies that align tightly with business goals - factoring in patents, regulatory exclusivity, and investment value.

She’s worked across a wide range of corporate transactions, from due diligence and licensing to acquisitions and spinouts. Her expertise is particularly valuable to SMEs preparing their patent portfolios for partnerships with larger companies. Sian has deep expertise in the pharmaceutical space, particularly around assets in development or already on the market. Her work covers areas such as Orange Book listing (in both the US and China), and strategic planning around patent expiry.

Sarah Grant

Chief Executive Officer, Stratagem IPM Ltd

Sarah has been an integral part of Stratagem for over 14 years, rising to CEO in 2022. She is deeply aligned with the firm’s values, particularly its emphasis on partnering with clients to provide comprehensive, strategic IP support. She is passionate about making IP accessible and commercially relevant - helping clients understand and leverage their IP for growth and success. She understands that how to commercialise and leverage innovation can be intimidating and confusing, particularly for new founders. Her job is to make the journey as smooth as possible, with clear jargon-free advice. She works with clients across the biotech fields to build and support their intellectual property strategy so that they can reach their commercial goals.